In sub-Saharan Africa, approximately 1 in 2 HIV-1-infected persons living in a couple have a
serodiscordant partner. Recent data suggest a large proportion of new HIV-1 infections in …

Background Antiretroviral therapy that reduces viral replication could limit the transmission
of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. Methods In nine …

Background Using a pilot system we have categorised this review as: Current question ‐
update pending (See "Published notes" section for an explanation). Traveller's diarrhoea is a …

Heterosexual exposure accounts for most HIV transmission in sub-Saharan Africa, and this
mode, as a proportion of new infections, is escalating globally. The scientific evidence …

Background Most persons who are infected with human immunodeficiency virus type 1 (HIV-1)
are also infected with herpes simplex virus type 2 (HSV-2), which is frequently reactivated …

Background Hormonal contraceptives are used widely but their effects on HIV-1 risk are
unclear. We aimed to assess the association between hormonal contraceptive use and risk of …

Background. The efficacy of condoms for protection against transmission of herpes simplex
virus type 2 (HSV-2) has been examined in a variety of populations with different effect …

Background The MRKAd5 HIV-1 gag/pol/nef subtype B vaccine was designed to elicit T-cell-mediated
immune responses capable of providing complete or partial protection from HIV-1 …

(See the editorial commentary by Gray and Wawer on pages 351–2 .) Background. Knowledge
of factors that affect per-act infectivity of human immunodeficiency virus type 1 (HIV-1) is …

Recombinant adenovirus serotype 5 (rAd5) vaccine vectors for HIV-1 and other pathogens
have been shown to be limited by high titers of Ad5 neutralizing antibodies (NAbs) in the …